Skip to main content
. 2022 Apr 7;14(4):814. doi: 10.3390/pharmaceutics14040814

Figure 1.

Figure 1

(a) Increase in free gadolinium (retention time close to 2.3 min) at different time points of the reaction followed by HPLC—ICP/MS. (b) Schematic view of the impact of the process on the nanoparticle starting from AGuIX® to obtain CuPRiX1 (3 h of reaction) and CuPRiX2 (4 h of reaction).